Protagonist Therapeutics, Inc. (PTGX) Earnings
NASDAQ·Healthcare·Biotechnology
$100.62
+2.14%
Mkt Cap $6.74B
Next Earnings
In 7 daysWed, May 6, 2026
EPS Estimate
-$0.65
6 analysts
Revenue Estimate
$12.20M
Last quarter: missed by -30.19% on EPS, -14.92% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$6.74B
P/E
—
Fwd P/E
26.94
P/S
146.36
Rev TTM
—
EPS TTM
-$2.05